OnePin Peptide Library · Metabolic
DIM (Diindolylmethane)
Diindolylmethane
Diindolylmethane (DIM) is a phytochemical formed from indole-3-carbinol (I3C) when cruciferous vegetables (broccoli, kale, cabbage, Brussels sprouts) are chewed and digested. I3C dimerizes in the acidic stomach environment to form DIM, which is the more bioavailable and stable active metabolite. While DIM occurs naturally in cruciferous vegetables, achieving therapeutic doses through diet alone requires impractical quantities (~2lb of broccoli daily for 100mg DIM).,DIM modulates estrogen metabolism by shifting the balance from less-favorable estrogen metabolites (16-alpha-hydroxyestrone, 4-hydroxyestrogens) toward more-favorable 2-hydroxyestrogens. The 2:16 hydroxyestrogen ratio is a marker of estrogen metabolism quality - higher ratios are associated with reduced breast and uterine cancer risk. DIM is one of the most clinically validated approaches to favorably shift this ratio.,DIM is widely used by men for estrogen management (especially when on testosterone replacement therapy or when aromatization is elevated) and by women for hormonal symptoms (estrogen dominance, fibroids, fibrocystic breasts, PCOS). It is NOT an aromatase inhibitor (does not reduce estrogen production) but rather modulates how estrogen is metabolized and cleared. This makes DIM a 'preserve cardioprotective estrogen, redirect harmful metabolites' tool rather than an estrogen-blocker.
Take with a meal containing fat for best absorption (DIM is fat-soluble). Start with 100mg/day to assess tolerance, titrate up to 200-300mg over 1-2 weeks. Monitor estradiol levels every 6-8 weeks if on TRT to avoid over-suppression.
Start here. Every protocol below is ordered lowest-first. Begin at the smallest effective dose, hold about a week to assess tolerance, and step up only if needed.
How it works
DIM induces cytochrome P450 1A1 (CYP1A1), the enzyme that hydroxylates estrogens at the 2-position to form 2-hydroxyestrone (2-OHE1) and 2-hydroxyestradiol. This shifts metabolism away from the 16-alpha-hydroxylation pathway (forms 16-alpha-hydroxyestrone, a more proliferative metabolite associated with cancer risk).,The 2-hydroxyestrogens are weaker estrogen receptor agonists, more easily methylated and excreted, and may have anti-proliferative effects. Increased 2:16 ratio is associated with reduced breast cancer risk in observational studies.,DIM modulates androgen receptor activity - has weak antagonist activity at androgen receptors in some tissues (relevant for prostate). It does NOT block testosterone systemically but may modify androgen signaling locally.,DIM activates the aryl hydrocarbon receptor (AhR), which has multiple downstream effects including induction of phase I and phase II detoxification enzymes (UGTs, GSTs, sulfotransferases). This supports general xenobiotic and estrogen clearance.,Anti-proliferative effects: DIM has been shown to induce apoptosis in cancer cell lines (breast, prostate, cervical) via cell cycle arrest, NF-kB inhibition, and modulation of survival signaling. Clinical relevance for cancer prevention/treatment is still being studied.,Aromatase: DIM is NOT a strong aromatase inhibitor at typical supplement doses. Its estrogen-management effects are post-aromatization (metabolite shifting) rather than blocking estrogen production.
DIM induces cytochrome P450 1A1 (CYP1A1), the enzyme that hydroxylates estrogens at the 2-position to form 2-hydroxyestrone (2-OHE1) and 2-hydroxyestradiol. This shifts metabolism away from the 16-alpha-hydroxylation pathway (forms 16-alpha-hydroxyestrone, a more proliferative metabolite associated with cancer risk).,The 2-hydroxyestrogens are weaker estrogen receptor agonists, more easily methylated and excreted, and may have anti-proliferative effects. Increased 2:16 ratio is associated with reduced breast cancer risk in observational studies.,DIM modulates androgen receptor activity - has weak antagonist activity at androgen receptors in some tissues (relevant for prostate). It does NOT block testosterone systemically but may modify androgen signaling locally.,DIM activates the aryl hydrocarbon receptor (AhR), which has multiple downstream effects including induction of phase I and phase II detoxification enzymes (UGTs, GSTs, sulfotransferases). This supports general xenobiotic and estrogen clearance.,Anti-proliferative effects: DIM has been shown to induce apoptosis in cancer cell lines (breast, prostate, cervical) via cell cycle arrest, NF-kB inhibition, and modulation of survival signaling. Clinical relevance for cancer prevention/treatment is still being studied.,Aromatase: DIM is NOT a strong aromatase inhibitor at typical supplement doses. Its estrogen-management effects are post-aromatization (metabolite shifting) rather than blocking estrogen production.
What to expect
Week 1-2: Initial metabolite shift, possible mild side effects (headache, urine color).
Evidence
Interactions & stacking
What's safe to combine, and what belongs in a separate pin.
Safe & synergistic
Keep separate
Pharmacokinetics
Storage. Store at room temperature (20-25C) in a cool, dry place. Protect from light. Capsules shelf-stable 2+ years.
Regulatory status
Classified as a dietary supplement in the US - no prescription required. Widely available. No FDA-approved medical indication.
Put it to work
Calculate, log & track
Open DIM (Diindolylmethane) straight into OnePin with your vial and dose pre-filled, then let it handle the syringe math and remind you before the vial runs out.
Open DIM (Diindolylmethane) in the app →Go deeper
The guide & community
The complete DIM (Diindolylmethane) walkthrough, real protocol discussion and coaching live inside the BlessUp community on Skool.
Join the community ↗